Navigation Links
FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
Date:5/4/2010

ts symptoms. Standard treatments include educational approaches, psychological or behavioral modification, and/or medication.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com .

THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceuti
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. FDA Approves New Device for Adults with Severe and Persistent Asthma
3. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
4. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
5. FDA Approves First Totally Implanted Hearing System
6. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Name Change for Heartburn Drug Kapidex
8. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
9. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
10. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
11. FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Unichem Pharmaceuticals ( ... one lot of Hydrochlorothiazide tablets 25 mg 1000-count bottle ... as a precautionary measure due to the identification of ... product. The risk associated with mistakenly ... is the increased probability of experiencing Clopidogrel,s side effects ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
(Date:7/30/2015)... YORK , July 30, 2015 /PRNewswire/ ... a new research report with market overview, ... share, forecast, porter analysis, recent developments, competitive ... Global Industry Insight: Biosensors Market Development ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... 14, 2011 Reportlinker.com announces that a new ... Endometrial Cancer Therapeutics - Pipeline ... http://www.reportlinker.com/p0479825/Endometrial-Cancer-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html Endometrial Cancer ... 2017 Summary ...
... Patient Safety Technologies, Inc. (the "Company", OTCQB: PSTX) ... full fiscal year end 2010. Financial ... hospitals using the Company,s SurgiCount Safety-Sponge® System more than ... proportional to future revenues, the number of hospitals using ...
Cached Medicine Technology:Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 2Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 3Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 4Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 5Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 6Patient Safety Technologies Reports Fiscal 2010 Fourth Quarter and Full Year Results 7
(Date:7/30/2015)... ... 2015 , ... The Clinical Data Interchange Standards Consortium (CDISC), ... that data standards for clinical research in the areas of Schizophrenia, Hepatitis C ... These three Therapeutic Area (TA) standards were developed per the CDISC global, consensus-based ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... for people on the go. With no water needed, the refreshing berry-flavored tablets ... simple way to get the natural ingredients that may help with body detoxification, ...
(Date:7/30/2015)... ... 2015 , ... Google recently announced that it will be disclosing any incidents ... a June 8, 2015 article published by Nasdaq , the powerful tech company ... its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe may ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Nursing Center,” to announce its position as one of Medicare’s top-rated care ... staff members support the CMS rating system, which monitors health inspections, staffing, ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is ... Tool That Increases Training Capability , World renown body weight trainer, Paul ... http://www.Zejax.com ), that dramatically increases a person’s training capability. , The American College ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
... ... measuring and ultimately eliminating pain , ... Washington, DC (Vocus) June 4, 2010 -- Children’s National Medical Center ... the Sheikh Zayed Institute for Pediatric Surgical Innovation. Dr. Quezado joins a team of ...
... researchers say , FRIDAY, June 4 (HealthDay News) ... Wii Sports -- may help overweight seniors become more ... Although not an improvement on real-life gaming and sports ... offer a good alternative for those older individuals for ...
... Device includes ,carbon nanotubes, injected under skin, say researchers ... future, people with diabetes may be able to monitor ... This new type of continuous glucose monitor relies on ... blood sugar levels with a watch-sized or smaller monitor ...
... , ... BP to reach out for help, said Golden Age Resources, Inc. (GDAR) CFO Graham Larmer. ... Hollywood, FL (PRWEB) June ... alliance partner, Cobra Technologies, announced today the hiring of Geometrix Engineering, Inc. of Hollywood, FL ...
... so rampant last spring, will adopt a regular fall/winter pattern, ... year ago, global alarm over the emergence of an unpredictable ... Headlines blared that thousands were becoming sick; face masks and ... store shelves. , So, where is H1N1 this spring? , ...
... Dogs ... only patented product invented by a professional dog trainer. Successfully used worldwide for nine ... (used with autistic children) and Acupressure to calm dogs. Susan Sharpe, inventor, also provides ... ...
Cached Medicine News:Health News:Former NIH Chief Joins Children's National Medical Center 2Health News:Former NIH Chief Joins Children's National Medical Center 3Health News:Wii Games Can Get Seniors Moving 2Health News:Glucose 'Tattoo' Could Track Blood Sugar Levels for Diabetics 2Health News:Glucose 'Tattoo' Could Track Blood Sugar Levels for Diabetics 3Health News:Gulf Oil Spill Goes from Disaster to Catastrophe 2Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 2Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 3Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 4Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 2Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 3Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 4
... Mini-TrueView Arthroscopes,Based on the TrueView II design, ... optic telescopes for small joint arthroscopy is ... autoclavable and very durable thanks to Olympus ... new telescope class means bright images, brilliant ...
... to provide excellent protection and ease of ... being closer to an adhesive in molecular ... CoEase to maintain viscosity at high shear ... worlds for superb performance during capsulorhexis, phaco, ...
151 channels cover the entire head with a high density, with provisions for the eyes and ears. Patients and subjects are examined in a comfortable seated position or laying down....
... for evaluating a wide range of functions of ... Often referred to at the "whole body" MSI ... spinal cord and peripheral nerve studies, are expanding ... detector coils, covers a circular area approximately 32 ...
Medicine Products: